The impact of sodium and potassium on hypertension risk

Seminars in Nephrology

Volumn 34, Issue 3, 2014, Pages 257-272

  Adrogué, Horacio J ^a,b,c   Madias, Nicolaos E ^d,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Cardiovascular risk; Potassium intake; Sodium intake; Sodium potassium ratio

Indexed keywords

PLACEBO; POTASSIUM; POTASSIUM CHLORIDE; RAMIPRIL; SODIUM; TELMISARTAN; POTASSIUM INTAKE; SODIUM INTAKE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FOOD COMPOSITION; FOOD INTAKE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE EXTRASYSTOLE; HEMODYNAMICS; HUMAN; HYPERTENSION; MORBIDITY; NONHUMAN; POTASSIUM DEFICIENCY; POTASSIUM INTAKE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; SODIUM POTASSIUM RATIO; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; UROGENITAL SYSTEM PARAMETERS; VASCULAR RESISTANCE; ADMINISTRATION AND DOSAGE; METABOLISM; PATHOPHYSIOLOGY; RISK;

HUMANS; HYPERTENSION; POTASSIUM; POTASSIUM DEFICIENCY; POTASSIUM, DIETARY; RISK; SODIUM; SODIUM, DIETARY;

EID: 84904006739     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2014.04.003     Document Type: Review

References (114)

1. Adrogué H.J., Madias N.E. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007, 356:1966-1978.
2. Simpson F.O. Blood pressure and sodium intake. Hypertension: pathology, diagnosis, and management 1990, 205-215. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
3. Midgley J.P., Matthew A.G., Greenwood C.M., Logan A.G. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996, 275:1590-1597.
4. Kotchen T.A., Cowley A.W., Frohlich E.D. Salt in health and disease-a delicate balance. N Engl J Med 2013, 368:1229-1237.
5. Adrogué H.J., Madias N.E. Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension. J Am Soc Hypertens 2014, 8:203-213.
6. Elliot P. Observational studies of salt and blood pressure. Hypertension 1991, 17. I-3-8.
7. Elliot P., Stamler J., Nichols R., et al. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996, 312:1249-1253.
8. Kaplan N.M. Primary hypertension: pathogenesis. Kaplan's clinical hypertension 2006, 50-121. Lippincott Williams & Wilkins, Philadelphia. 9th ed. N.M. Kaplan (Ed.).
9. Conway J. Hemodynamics in mineralocorticoid hypertension: handbook of hypertension. Pathophysiology of hypertension-cardiovascular aspects 1986, Vol 7:217-224. Amsterdam: Elsevier Science B.V.
10. Law M.R., Frost C.D., Wald N.J. By how much does dietary salt reduction lower blood pressure? Analysis of observational data among populations. BMJ 1991, 302:811-815.
11. Simons-Morton D.G., Obarzanek E. Diet and blood pressure in children and adolescents. Pediatr Nephrol 1997, 11:244-249.
12. Intersalt Cooperative Research group. Intersalt: an International study of electrolyte excretion and blood pressure: results for 24-hour urinary sodium and potassium excretion. BMJ 1988, 297:319-328.
13. Cutler J.A., Follmann D., Allender P.S. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997, 65(Suppl):643S-651SS.
14. Denton D., Weisinger R., Mundy N.I., Wickings E.J., Dixson A., Moisson P., et al. The effect of increased salt intake on blood pressure in chimpanzees. Nat Med 1995, 1:1009-1016.
15. Elliot P., Walker L.L., Little M.P., Blair-West J.R., Shade R.E., Lee R., et al. Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation 2007, 116:1563-1568.
16. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001, 344:3-10.
17. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of world-wide data. Lancet 2005, 365:217-223.
18. Institute of Medicine. Sodium intake in populations: assessment of evidence. Washington, DC: National Academies Press. [cited 2013 May]. Available from:. http://www.iom.edu/Reports/2013/Sodium-Intake-in-Populations-Assessment-ofEvidence.aspx.
19. Bibbins-Domingo K., Chertow G.M., Coxson P.G., et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010, 362:590-599.
20. Strazzullo P., D'Elia L., Kandala N.B., Cappuccio F.P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567.
21. Karppanen H., Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006, 49:59-75.
22. Laatikainen T., Pietinen P., Valsta L., Sundvall J., Reinivuo H., Tuomilehto J. Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Eur J Clin Nutr 2006, 60:965-970.
23. Cappuccio F.P., Capewell S., Lincoln P., McPherson K. Policy options to reduce population salt intake. BMJ 2011, 343:d4995.
24. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011, 305:1777-1785.
25. O'Donnell M.J., Yusuf S., Mente A., et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
26. Taylor R.S., Ashton K.E., Moxham T., Hooper L., Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2011, 7. (CD009217).
27. He F.J., MacGregor G.A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011, 378:380-382.
28. He F.J., Appel L.J., Cappucio F.P., de Wardener H.E., MacGregor G.A. Does reducing salt intake increase cardiovascular mortality?. Kidney Int 2011, 80:696-698.
29. Whelton P.K. Urinary sodium and cardiovascular disease risk. JAMA 2011, 306:2262-2264.
30. Whelton P.K., Appel L.J., Sacco R.L., Anderson C.A.M., Antman E.M., Campbell N., et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012, 126:2880-2889.
31. McCarron D.A., Geerling J.C., Kazaks A.G., Stern J.S. Can dietary sodium intake be modified by public policy?. Clin J Am Soc Nephrol 2009, 4:1878-1882.
32. Alderman M.H., Cohen H.W. Dietary sodium intake and cardiovascular mortality: controversy resolved?. Curr Hypertens Rep 2012, 14:193-201.
33. Thomas M.C., Morgan J., Forsblom C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
34. Ekinci E.I., Clarke S., Thomas M.C., et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
35. Sealey J.E., Alderman M.H., Furberg C.D., Laragh J.H. Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. Am J Hypertens 2013, 26:727-738.
36. Addison W.L.T. The use of sodium chloride, potassium chloride, sodium bromide, and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can Med Assoc J 1928, 18:281-285.
37. Kempner W. Compensation of renal metabolic dysfunction. Treatment of kidney disease and hypertensive vascular disease with rice diet. North Carolina Med J 1945, 6:61-87.
38. Morris R.C., Sebastian A., Forman A.H., Peeks R.A. Potassium bicarbonate has greater antihypertensive potency than potassium chloride in patients with essential hypertension [abstract]. J Am Soc Nephrol 1993, 3:533.
39. Tanaka M., Schmidlin O., Yi S.L., Bollen A.W., Morris R.C. Genetically determined chloride-sensitive hypertension and stroke. Proc Natl Acad Sci U S A 1997, 94:14748-14752.
40. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117-1124.
41. Cappuccio F.P., MacGregor G.A. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991, 9:465-473.
42. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., et al. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997, 277:1624-1632.
43. Obel A.O. Placebo-controlled trial of potassium supplements in black patients with mild essential hypertension. J Cardiovasc Pharmacol 1989, 14:294-296.
44. Aburto N.J., Hanson S., Gutierrez H., Hooper L., Elliot P., Cappuccio F.P. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013, 346:11378.
45. Skrabal F., Auböck J., Hörtnagl H. Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet 1981, 2:895-900.
46. Khaw K.T., Thom S. Randomised double-blind cross-over trial of potassium on blood-pressure in normal subjects. Lancet 1982, 2:1127-1129.
47. Zoccali C., Cumming A.M., Hutcheson M.J., Barnett P., Semple P.F. Effects of potassium on sodium balance, renin, noradrenaline and arterial pressure. J Hypertens 1985, 3:67-72.
48. Weissberg P.L., West M.J., Kendall M.J., Ingram M., Woods K.L. Effect of changes in dietary sodium and potassium on blood pressure and cellular electrolyte handling in young normotensive subjects. J Hypertens 1985, 3:475-480.
49. Barden A.E., Vandongen R., Beilin L.J., Margetts B., Rogers P. Potassium supplementation does not lower blood pressure in normotensive women. J Hypertens 1986, 4:339-343.
50. Poulter N.R., Sever P.S. Moderate potassium supplementation: ineffective in black normotensives. East Afr Med J 1986, 63:798-802.
51. Mullen J.T., O'Connor D.T. Potassium effects on blood pressure: Is the conjugate anion important?. J Hum Hypertens 1990, 4:589-596.
52. Barden A., Beilin L.J., Vandongen R., Puddey I.B. A double-blind placebo-controlled trial of the effects of short-term potassium supplementation on blood pressure and atrial natriuretic peptide in normotensive women. Am J Hypertens 1991, 4:206-213.
53. Whelton P.K., Buring J., Borhani N.O., et al. The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol 1995, 5:85-95.
54. Brancati F.L., Appel L.J., Seidler A.J., Whelton P.K. Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med 1996, 156:61-67.
55. Whelton P.K. Potassium and blood pressure. Hypertension primer 2003, 280-282. American Heart Association/Council on High Blood Pressure Research, Dallas. 3rd ed. J.L. Izzo, H.R. Black (Eds.).
56. Rose G. Desirability of changing potassium intake in the community. Potassium in cardiovascular and renal medicine 1986, 411-416. Marcel Dekker, New York. P.K. Whelton, A. Whelton, W.G. Walker (Eds.).
57. Grimm R.H., Neaton J.D., Elmer P.J., Svendsen K.H., Levin J., Segal M., et al. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med 1990, 322:569-574.
58. MacGregor G.A., Smith S.J., Markandu N.D., Banks R.A., Sagnella G.A. Moderate potassium supplementation in essential hypertension. Lancet 1982, 2:567-570.
59. Richards A.M., Nicholls M.G., Espiner E.A., et al. Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet 1984, 1:757-761.
60. Chalmers J., Morgan T., Doyle A., et al. Australian National Health and Medical Research Council Dietary Salt Study in Mild Hypertension. J Hypertens 1986, 4:S629-S637.
61. Matlou S.M., Isles C.G., Higgs A., et al. Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens 1986, 4:61-64.
62. Siani A., Strazzullo P., Russo L., et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J (Clin Res Ed) 1987, 294:1453-1456.
63. Cushman W.C., Langford H.G. Randomized controlled trial of potassium chloride versus placebo in mildly hypertensive blacks and whites. Circulation 1988, 78:II-370.
64. Patki P.S., Singh J., Gokhale S.V., Bulakh P.M., Shrotri D.S., Patwardhan B. Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ 1990, 301:521-523.
65. Valdés G., Vio C.P., Montero J., Avendaño R. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J Hum Hypertens 1991, 5(66):91-96.
66. Fotherby M.D., Potter J.F. Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens 1992, 10:1403-1408.
67. Smith S.R., Klotman P.E., Svetkey L.P. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol 1992, 2:1302-1309.
68. Kaplan N.M., Carnegie A., Raskin P., Heller J.A., Simmons M. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 1985, 312:746-749.
69. Biglieri E.G., Mcllroy M.B. Abnormalities of renal function and circulatory reflexes in primary aldosteronism. Circulation 1966, 33:78-86.
70. Hall J.E., Guyton A.C. Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotensin system. Hypertension: pathophysiology, diagnosis, and management 1990, 1105-1129. Raven Press, New York. J.H. Laragh, B.M. Brenner (Eds.).
71. Siani A., Strazzullo P., Giacco A., Pacioni D., Celentano E., Mancini M. Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med 1991, 115:753-759.
72. Meneely G.R., Ball C.O.T. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am J Med 1958, 25:713-725.
73. Meneely G.R., Lemley-Stone J., Darby W.J. Changes in blood pressure and body sodium of rats fed sodium and potassium chloride. Am J Cardiol 1961, 8:527-532.
74. Dahl L.K., Leitl G., Heine M. Influence of dietary potassium and sodium/potassium molar ratios on the development of salt hypertension. J Exp Med 1972, 136:318-330.
75. Mills E.H., Coghlan J.P., Denton D.A., Spence C.D., Whitworth J.A., Scoggins B.A. The anti-hypertensive effect of potassium loading in experimental hypertension: a comparison of sheep with other species. Clin Exp Hypertens A 1988, 10:289-309.
76. Anderson D.E., Kearns W.D., Worden T.J. Potassium infusion attenuates avoidance-saline hypertension in dogs. Hypertension 1983, 5:415-420.
77. Fujita T., Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA- salt hypertensive rats. Kidney Int 1983, 24:731-739.
78. Tobian L., Lange J., Ulm K., Wold L., lwai J. Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension 1985, 7(Suppl I):1-110-4.
79. Tobian L. Evidence for a protective effect of potassium on renal function and cerebral arteries and arterioles. Potassium in cardiovascular and renal medicine 1986, 391-396. Marcel Dekker, New York. P.K. Whelton, A. Whelton, W.G. Walker (Eds.).
80. Ellis D., Banner B., Janosky J.E., Feig P.U. Potassium supplementation attenuates experimental hypertensive renal injury. J Am Soc Nephrol 1992, 2:1529-1537.
81. Perera G.A. Depressor effects of potassium-deficient diets in hypertensive man. J Clin Invest 1953, 32:633-636.
82. Freed S.C., Friedman M. Depressor effect of potassium restriction on blood pressure of the rat. Proc Soc Exp Biol Med 1951, 78:74-77.
83. Abbrecht P.H. Cardiovascular effects of chronic potassium deficiency in the dog. Am J Physiol 1972, 223:555-560.
84. Benedetti R.G., Linas S.L. Effect of potassium depletion on two-kidney, one-clip renovascular hypertension in the rat. Kidney Int 1985, 28:621-628.
85. Krishna G.G., Miller E., Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989, 320:1177-1182.
86. Krishna G.G., Kapoor S.C. Potassium depletion exacerbates essential hypertension. Ann Intern Med 1991, 115:77-83.
87. Luft F.C. Can non-pharmacological interventions reduce doses of drugs needed for the treatment of hypertension?. World Hypertension League (WHL) 1993, 69-77. Yearbook, Geneva. D. Ganten, T. Strasser, J. Potzsch (Eds.).
88. Dolson G.M., Ellis K.J., Bernardo M.V., Prakash R., Adrogué H.J. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 1995, 26:321-326.
89. Dolson G.M., Wesson D.E., Adrogué H.J. Vascular relaxation probably mediates the antihypertensive effect of a high-potassium diet: a role for enhanced vascular Na, K-ATPase activity. J Hypertens 1995, 13:1433-1439.
90. Dolson G.M., Adrogué H.J. Low dialysate [K+] decreases efficiency of hemodialysis and increases urea rebound. J Am Soc Nephrol 1998, 9:2124-2128.
91. Suga S.-I., Phillips M.I., Ray P.E., Raleigh J.A., Vio C.P., Kim Y., et al. Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am J Physiol Renal Physiol 2001, 281:F620-F629.
92. Suga S.-I., Mazzali M., Ray P.E., Kang D., Johnson R.J. Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency. Kidney Int 2002, 61:951-958.
93. Wang W., Soltero L., Zhang P., Huang X.R., Lan H.Y., Adrogué H.J. Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. Am J Physiol Renal Physiol 2007, 293:F1123-F1130.
94. Elliott P. Salt and blood pressure. /Council on High Blood Pressure Research 2003, 277-279. American Heart Association, Dallas. J.L. Izzo, H.R. Black (Eds.).
95. He J., Whelton P.K. Potassium, blood pressure, and cardiovascular disease: an epidemiologic perspective. Cardiol Rev 1997, 5:255-260.
96. Cruz-Coke R., Etcheverry R., Nagel R. Influences of migration on blood-pressure of Easter Islanders. Lancet 1964, 15:697-699.
97. Ward R.H., Chin P.G., Prior IAM. TokeIau Island Migrant Study: effect of migration on the familial aggregation of blood pressure. Hypertension 1980, 2:143-154.
98. Adrogué H.J., Wesson D.E. Role of dietary factors in the hypertension of African Americans. Semin Nephrol 1996, 16:94-101.
99. Hansen J. Blood volume and exchangeable sodium in essential hypertension. Acta Med Scand 1968, 184:517-523.
100. Lever A.F., Beretta-Piccoli C., Brown J.J., Davies D.L., Fraser R., Robertson J.I.S. Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) 1981, 283:463-468.
101. Kopp C., Linz P., Wachsmuth L., et al. Na magnetic resonance imaging of tissue sodium. Hypertension 2012, 59:167-172.
102. Ericsson F. Potassium in skeletal muscle in untreated primary hypertension and in chronic renal failure, studied by X-ray fluorescence technique. Acta Med Scand 1984, 215:225-230.
103. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academies Press, 2005.
104. Guideline: Potassium Intake for Adults and Children 2012, World Health Organization, World Health Organization, Geneva, Switzerland.
105. Chang H.-Y., Hu Y.-W., Yue C.-S.J., et al. Effect of potassium enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006, 83:1289-1296.
106. Cook N.R., Cutler J.A., Obarzanek B., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ 2007, 334:885-888.
107. Cook N.R., Obarzanek E., Cutler J.A., et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease. The Trials of Hypertension Prevention Follow-up Study. Arch Intern Med 2009, 169:32-40.
108. Adrogué H.J., Madias N.E. Shared primacy of sodium and potassium on cardiovascular risk. Am J Kidney Dis 2009, 54:598-601.
109. He J., Gu D., Chen J., et al. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens 2009, 27:48-54.
110. Yang Q., Liu T., Kuklina E.V., et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011, 171:1183-1191.
111. Teramoto T., Kawamori R., Miyazaki S., Teramukai S. Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study. Hypertens Res 2011, 34:957-962.
112. Rodriguez C.J., Bibbins-Domingo K., Jin Z., Daviglus M.L., Goff D.C., Jacobs D.R. Association of sodium and potassium intake with left ventricular mass; coronary artery risk development in young adults. Hypertension 2011, 58:410-416.
113. Hedayati S.S., Minhajuddin A.T., Ijaz A., Moe O.W., Elsayed E.F., Reilly R.F., et al. Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol 2012, 7:315-322.
114. Marketou M.E., Zacharis E.A., Parthenakis F., Kochiadakis G.E., Maragkoudakis S., Chlouverakis G., et al. Association of sodium and potassium intake with ventricular arrhythmic burden in patients with essential hypertension. J Am Soc Hypertens 2013, 7:276-282.